Completed NCT03345979
This study is completed in the United States. It is testing aripiprazole Lauroxil or Paliperidone Palmitate for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries United States
Sponsor Alkermes, Inc.
Condition Schizophrenia Completed NCT00839852
This study is completed in the United States, in India, in Malaysia, .... It is testing cariprazine for schizophrenia.
Multiple locations, including Costa Mesa Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 61 Years
Countries United States, India, Malaysia, ...
Sponsor Forest Laboratories
Condition Schizophrenia Completed NCT01412060
This study is completed in the United States, in India, in Romania, .... It is testing cariprazine for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 60 Years
Countries United States, India, Romania, ...
Sponsor Forest Laboratories
Condition Schizophrenia Completed NCT00086320
This study is completed. It is testing Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia Completed NCT00791232
This study is completed. It is testing Extended Release Extended-release (ER) OROS Paliperidone Tolerability, for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia Completed NCT01541371
This study is completed. It is testing flexibly Dosed Paliperidone Extended Release Tablets for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries
Sponsor Xian-Janssen Pharmaceutical Ltd.
Condition Schizophrenia Completed NCT03393026
This study is completed in Taiwan. It is testing Lurasidone HCl for schizophrenia.
In Taipei Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 20 Years to 75 Years
Countries Taiwan
Sponsor Standard Chem. & Pharm. Co., Ltd.
Condition Schizophrenia Completed NCT00970281
This study is completed in Japan. It is testing olanzapine for schizophrenia.
Multiple locations, including Aichi Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 20 Years to 64 Years
Countries Japan
Sponsor Eli Lilly and Company
Condition Schizophrenia Completed NCT01110317
This study is completed. It is testing paliperidone Blood Concentrations for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia Completed NCT01529515
This study is completed in the United States, in Colombia, in Malaysia, .... It is testing Paliperidone Palmitate 3 Month Formulation for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 70 Years
Countries United States, Colombia, Malaysia, ...
Sponsor Janssen Research & Development, LLC
Condition Schizophrenia Completed NCT01258920
This study is completed in Japan. It is testing paliperidone Palmitate for schizophrenia.
Multiple locations, including Asahi Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 20 Years
Countries Japan
Sponsor Janssen Pharmaceutical K.K.
Condition Schizophrenia Completed NCT01685931
This study is completed in China. It is testing paliperidone Palmitate for schizophrenia.
Multiple locations, including Baoding Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries China
Sponsor Xian-Janssen Pharmaceutical Ltd.
Condition Schizophrenia